Tower Research Capital LLC (Trc) Repligen Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Repligen Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,452 shares of RGEN stock, worth $221,241. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,452
Previous 1,448
0.28%
Holding current value
$221,241
Previous $180,000
7.78%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding RGEN
# of Institutions
529Shares Held
59.2MCall Options Held
321KPut Options Held
667K-
Black Rock Inc. New York, NY7.57MShares$1.15 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$769 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$534 Million0.05% of portfolio
-
United Capital Financial Advisers, LLC Newport Beach, CA2.76MShares$420 Million2.74% of portfolio
-
State Street Corp Boston, MA1.8MShares$275 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.46B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....